Michael Goldsmith

Stock Analyst at UBS

(3.76)
# 2,065
Out of 5,136 analysts
467
Total ratings
57.3%
Success rate
4.5%
Average return

Stocks Rated by Michael Goldsmith

BXP, Inc.
Nov 13, 2026
Rated: Hold
Price Target: $70 → $66
Current: $63.91
Upside: +3.27%
American Healthcare REIT
Nov 11, 2026
Rated: Buy
Price Target: $62 → $71
Current: $58.07
Upside: +22.27%
Brixmor Property Group
Nov 11, 2026
Reiterated: Buy
Price Target: $33 → $35
Current: $30.41
Upside: +15.09%
Americold Realty Trust
Nov 11, 2026
Rated: Hold
Price Target: $14 → $16
Current: $16.65
Upside: -3.90%
CareTrust REIT
Nov 11, 2026
Rated: Buy
Price Target: $44 → $46
Current: $37.39
Upside: +23.03%
Healthpeak Properties
Nov 11, 2026
Rated: Hold
Price Target: $20 → $22
Current: $19.84
Upside: +10.89%
Federal Realty Investment Trust
Nov 11, 2026
Rated: Hold
Price Target: $115 → $121
Current: $113.99
Upside: +6.15%
Healthcare Realty Trust
Nov 11, 2026
Rated: Hold
Price Target: $18 → $20
Current: $19.32
Upside: +3.52%
Kimco Realty
Nov 11, 2026
Rated: Buy
Price Target: $25 → $29
Current: $25.73
Upside: +12.71%
Kite Realty Group Trust
Nov 11, 2026
Rated: Hold
Price Target: $26 → $27
Current: $25.48
Upside: +5.97%
Rated: Buy
Price Target: $52 → $56
Current: $47.08
Upside: +18.95%
Rated: Hold
Price Target: $42 → $45
Current: $41.24
Upside: +9.12%
Rated: Hold
Price Target: $77 → $82
Current: $76.58
Upside: +7.08%
Rated: Hold
Price Target: $20 → $22
Current: $20.35
Upside: +8.11%
Rated: Hold
Price Target: $205 → $235
Current: $232.78
Upside: +0.95%
Rated: Hold
Price Target: $21 → $22
Current: $20.98
Upside: +4.86%
Rated: Hold
Price Target: $90 → $99
Current: $88.88
Upside: +11.39%
Rated: Buy
Price Target: $269 → $289
Current: $244.65
Upside: +18.13%
Rated: Hold
Price Target: $32 → $34
Current: $32.52
Upside: +4.55%
Reiterated: Hold
Price Target: $38 → $44
Current: $44.85
Upside: -1.90%
Reiterated: Buy
Price Target: $152 → $174
Current: $158.23
Upside: +9.97%
Reiterated: Hold
Price Target: $294 → $334
Current: $333.71
Upside: +0.09%
Reiterated: Hold
Price Target: $117
Current: $119.01
Upside: -1.69%
Rated: Hold
Price Target: $45 → $36
Current: $34.85
Upside: +3.30%
Rated: Buy
Price Target: $35 → $31
Current: $27.10
Upside: +14.39%
Reiterated: Buy
Price Target: $67
Current: $62.35
Upside: +7.46%
Rated: Buy
Price Target: $73
Current: $64.75
Upside: +12.74%
Reiterated: Buy
Price Target: $91
Current: $69.35
Upside: +31.22%
Rated: Hold
Price Target: $20
Current: $17.55
Upside: +13.96%
Rated: Hold
Price Target: $58
Current: $60.21
Upside: -3.67%
Rated: Buy
Price Target: $40
Current: $27.72
Upside: +44.30%
Rated: Buy
Price Target: $30
Current: $23.18
Upside: +29.42%
Rated: Hold
Price Target: $33
Current: $28.76
Upside: +14.74%
Rated: Hold
Price Target: $45
Current: $40.83
Upside: +10.21%
Rated: Buy
Price Target: $24
Current: $18.56
Upside: +29.31%
Rated: Buy
Price Target: $72
Current: $58.55
Upside: +22.97%
Rated: Hold
Price Target: $20
Current: $16.47
Upside: +18.40%
Rated: Hold
Price Target: $75
Current: $66.08
Upside: +13.50%
Rated: Hold
Price Target: $132
Current: $117.82
Upside: +12.04%
Rated: Hold
Price Target: $278
Current: $273.46
Upside: +1.66%
Reiterated: Hold
Price Target: $108 → $106
Current: $99.16
Upside: +6.90%
Rated: Buy
Price Target: $148 → $161
Current: $127.60
Upside: +26.18%
Reiterated: Buy
Price Target: $41 → $42
Current: $36.37
Upside: +15.48%
Reiterated: Buy
Price Target: $360 → $380
Current: $652.26
Upside: n/a